联系电话: 400 008 0586; 0755-82571568
微信扫码:
1.MARKETOVERVIEW
·Introduction
DiseaseCharacteristics
Epidemiology
·MarketDefinitionandSegmentation
Definition
Segmentation
2.RESEARCHMETHODOLOGY
·ResearchObjectivesandScope
ResearchMethodology
3.INDUSTRYCHALLENGES
·ChallengesForTheAsthmaTherapeuticsMarket
ChallengesFacedbythePharmaceuticalCompanies
4.EUROPEANASTHMATHERAPEUTICSMARKET
·OverviewandDefinitions
Introduction
MarketEngineeringMeasurementsAnalysis
MarketDrivers
MarketRestraints
CurrentTherapeuticOptions
FutureTherapeuticApproaches
CurrentTreatmentGuidelines
RegulatoryAffairs
·CompetitiveAnalysis
ProfilesofKeyIndustryParticipants
MarketShareAnalysis
5.FORECASTSFORTHEEUROPEANASTHMATHERAPEUTICSMARKET
·Forecasts
PatientForecasts
MarketRevenueForecasts
MarketShareAnalysisByDrugClass
ForecastsofRecentEntrants-Xolair
6.PRICINGANDREIMBURSEMENTINEUROPE
·FactorsAffectingPricingandReimbursementinEurope
PricingandReimbursement
7.STRATEGICRECOMMENDATIONSFORTHEEUROPEANASTHMATHERAPEUTICSMARKET
·MarketEngineeringRecommendations
StrategicRecommendations
8.DATABASEOFKEYINDUSTRYPARTICIPANTS
·KeyIndustryParticipants
KeyParticipantsintheAsthmaTherapeuticsMarket
9.DECISIONSUPPORTDATABASES
·DSDTables
DSD1
DSD2
DSD3
DSD4
This Frost & Sullivan research service titled European Asthma Therapeutics Markets provides key challenges, forecasts and recommendations for the asthma therapeutics market. In this research, Frost & Sullivan' s expert analysts thoroughly examine the following markets: short acting beta 2 agonists, inhaled corticosteroids, combination therapies and leukotriene antagonists.
This analysis is available through our Pharmaceuticals and Biotechnology Growth Partnership Service programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.